Food and Drug Administration

New drug shows promise for treating Lou Gehrig's disease

New drug shows promise for treating Lou Gehrig's disease

The Food and Drug Administration recently approved the first new drug in more than two decades to treat ALS, the disease more commonly known as Lou Gehrig's disease that attacks and kills the nerves that control muscles.

About 12,000 to 15,000 Americans have ALS, which causes nerves to lose the capability to activate muscles and leads to paralysis, according to the Centers for Disease Control. Most people with ALS die from respiratory failure, usually within three to five years of diagnosis.

The FDA in May approved the use of the drug Radicava to treat ALS after a successful trial in Japan. Riluzole, the only other drug that was available to treat the disease, was approved for...

73°